CN Patent

CN1953741B — 欧司哌米芬的固体制剂

Assigned to Hormos Medical Ltd Oy · Expires 2011-03-30 · 15y expired

What this patent protects

本发明涉及包括含有作为治疗活性化合物的欧司哌米芬(也称为(去氨基羟基)托瑞米芬)或者其几何异构体、立体异构体、药学上可接受的盐、酯或者代谢产物与一种或多种颗粒内赋形剂相结合的颗粒的固体药物制剂。

USPTO Abstract

本发明涉及包括含有作为治疗活性化合物的欧司哌米芬(也称为(去氨基羟基)托瑞米芬)或者其几何异构体、立体异构体、药学上可接受的盐、酯或者代谢产物与一种或多种颗粒内赋形剂相结合的颗粒的固体药物制剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN1953741B
Jurisdiction
CN
Classification
—
Expires
2011-03-30
Drug substance claim
No
Drug product claim
No
Assignee
Hormos Medical Ltd Oy
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.